论文部分内容阅读
Objective Purpose: IDO1 and COX2 have emerged as promising immunotherapy targets,and their inhibitors could enhance T cell responses to tumor cells.Cyclooxygenase-2(COX-2)and prostaglandin E2(PGE2)expression drive constitutive expression of IDO1 in many human tumor cells through the PKC and PI3K pathways.